Literature DB >> 19636326

Reappraising the stereotypes of diabetes in the modern diabetogenic environment.

John M Wentworth1, Spiros Fourlanos, Leonard C Harrison.   

Abstract

The prevailing concentration of blood glucose is a result of the integrated regulation of insulin secretion and insulin action. Nevertheless, the classic stereotypes of diabetes are dichotomous: type 1 diabetes mellitus (T1DM) is attributed to impaired insulin secretion, and type 2 diabetes mellitus (T2DM) is primarily attributed to impaired insulin action (insulin resistance). The available evidence indicates that this view is overly simplistic. Impaired insulin secretion (beta-cell dysfunction) is also a feature of T2DM, and insulin resistance is also a risk factor for the development of T1DM. Moreover, with the increasing incidence of T2DM and T1DM in both developed and developing countries, attributed to environmental factors, the existence of 'hybrid' diabetes types that have clinical and pathogenetic features of both conditions is becoming clearly evident. A common thread across the spectrum of diabetes might be the activation of innate immunological and inflammatory pathways by a proinflammatory environment, which leads to beta-cell dysfunction in T2DM, insulin resistance in both T2DM and T1DM, and enhanced adaptive immunity that kills beta cells in T1DM. Embracing a holistic view of the diabetes syndrome will help us to understand the environmental basis for the epidemic of diabetes and improve preventative strategies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19636326     DOI: 10.1038/nrendo.2009.149

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  66 in total

1.  Declassifying diabetes.

Authors:  E A M Gale
Journal:  Diabetologia       Date:  2006-09       Impact factor: 10.122

2.  Impact of sleep debt on metabolic and endocrine function.

Authors:  K Spiegel; R Leproult; E Van Cauter
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

3.  Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages.

Authors:  P Hutchings; H Rosen; L O'Reilly; E Simpson; S Gordon; A Cooke
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

4.  Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes.

Authors:  D R Laybutt; A M Preston; M C Akerfeldt; J G Kench; A K Busch; A V Biankin; T J Biden
Journal:  Diabetologia       Date:  2007-02-01       Impact factor: 10.122

Review 5.  Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders.

Authors:  Sho-ichi Yamagishi; Seiji Ueda; Seiya Okuda
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

Review 6.  Vitamin D deficiency: a worldwide problem with health consequences.

Authors:  Michael F Holick; Tai C Chen
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

7.  Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals.

Authors:  David Patsouris; Ping-Ping Li; Divya Thapar; Justin Chapman; Jerrold M Olefsky; Jaap G Neels
Journal:  Cell Metab       Date:  2008-10       Impact factor: 27.287

8.  The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients.

Authors:  A M Borissova; T Tankova; G Kirilov; L Dakovska; R Kovacheva
Journal:  Int J Clin Pract       Date:  2003-05       Impact factor: 2.503

9.  Weight gain in early life predicts risk of islet autoimmunity in children with a first-degree relative with type 1 diabetes.

Authors:  Jennifer J Couper; Sarah Beresford; Craig Hirte; Peter A Baghurst; Angie Pollard; Brian D Tait; Leonard C Harrison; Peter G Colman
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 17.152

10.  The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes.

Authors:  Spiros Fourlanos; Michael D Varney; Brian D Tait; Grant Morahan; Margo C Honeyman; Peter G Colman; Leonard C Harrison
Journal:  Diabetes Care       Date:  2008-05-16       Impact factor: 19.112

View more
  13 in total

1.  Stem cells and a cure for type 1 diabetes?

Authors:  John A Todd
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-09       Impact factor: 11.205

Review 2.  The Interconnection Between Immuno-Metabolism, Diabetes, and CKD.

Authors:  Fabrizia Bonacina; Andrea Baragetti; Alberico Luigi Catapano; Giuseppe Danilo Norata
Journal:  Curr Diab Rep       Date:  2019-03-19       Impact factor: 4.810

Review 3.  AGE restriction in diabetes mellitus: a paradigm shift.

Authors:  Helen Vlassara; Gary E Striker
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

Review 4.  An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.

Authors:  Km Neelofar; Jamal Ahmad
Journal:  Glycoconj J       Date:  2017-08-15       Impact factor: 2.916

Review 5.  2011 Update: antigen-specific therapy in type 1 diabetes.

Authors:  Aaron W Michels; Matthias von Herrath
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2011-08       Impact factor: 3.243

Review 6.  Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition.

Authors:  Iqra Hameed; Shariq R Masoodi; Shahnaz A Mir; Mudasar Nabi; Khalid Ghazanfar; Bashir A Ganai
Journal:  World J Diabetes       Date:  2015-05-15

7.  Bimodal effect on pancreatic β-cells of secretory products from normal or insulin-resistant human skeletal muscle.

Authors:  Karim Bouzakri; Peter Plomgaard; Thierry Berney; Marc Y Donath; Bente Karlund Pedersen; Philippe A Halban
Journal:  Diabetes       Date:  2011-03-04       Impact factor: 9.461

8.  Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.

Authors:  Weijing Cai; Maya Ramdas; Li Zhu; Xue Chen; Gary E Striker; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

9.  Identification of a SIRT1 mutation in a family with type 1 diabetes.

Authors:  Anna Biason-Lauber; Marianne Böni-Schnetzler; Basil P Hubbard; Karim Bouzakri; Andrea Brunner; Claudia Cavelti-Weder; Cornelia Keller; Monika Meyer-Böni; Daniel T Meier; Caroline Brorsson; Katharina Timper; Gil Leibowitz; Andrea Patrignani; Remy Bruggmann; Gino Boily; Henryk Zulewski; Andreas Geier; Jennifer M Cermak; Peter Elliott; James L Ellis; Christoph Westphal; Urs Knobel; Jyrki J Eloranta; Julie Kerr-Conte; François Pattou; Daniel Konrad; Christian M Matter; Adriano Fontana; Gerhard Rogler; Ralph Schlapbach; Camille Regairaz; José M Carballido; Benjamin Glaser; Michael W McBurney; Flemming Pociot; David A Sinclair; Marc Y Donath
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

10.  Metoclopramide nanoparticles modulate immune response in a diabetic rat model: association with regulatory T cells and proinflammatory cytokines.

Authors:  Noura H Abd Ellah; Esraa A Ahmed; Rasha B Abd-Ellatief; Marwa F Ali; Asmaa M Zahran; Helal F Hetta
Journal:  Int J Nanomedicine       Date:  2019-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.